Precigen, Inc. (PGEN)

Precigen Inc. (formerly known as Intrexon Corporation) is a biotechnology company that uses synthetic biology to create biologically based products and solutions. Precigen has developed several platforms that use DNA-based technologies to address issues in a variety of fields, including health, food, energy, and the environment. The company has several subsidiaries, each of which is focused on a different area of research and development. For example, its subsidiary, ActoBio Therapeutics, is developing a new class of biotherapeutics for the treatment of autoimmune and inflammatory diseases. Precigen also has a subsidiary, AquaBounty Technologies, which is focused on the development of aquaculture technologies to increase the efficiency and sustainability of fish farming. The company is headquartered in Germantown, Maryland, USA.